• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特异性 Kv1.3 阻断剂可调节 ox-LDL 作用下人巨噬细胞中关键的胆固醇代谢相关分子。

Specific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL.

机构信息

Department of Cardiology, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.

出版信息

J Lipid Res. 2013 Jan;54(1):34-43. doi: 10.1194/jlr.M023846. Epub 2012 Oct 24.

DOI:10.1194/jlr.M023846
PMID:23099443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3520537/
Abstract

Cholesterol-metabolism-associated molecules, including scavenger receptor class A (SR-A), lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), CD36, ACAT1, ABCA1, ABCG1, and scavenger receptor class B type I, can modulate cholesterol metabolism in the transformation from macrophages to foam cells. Voltage-gated potassium channel Kv1.3 has increasingly been demonstrated to play an important role in the modulation of macrophage function. Here, we investigate the role of Kv1.3 in modulating cholesterol-metabolism-associated molecules in human acute monocytic leukemia cell-derived macrophages (THP-1 macrophages) and human monocyte-derived macrophages exposed to oxidized LDL (ox-LDL). Human Kv1.3 and Kv1.5 channels (hKv1.3 and hKv1.5) are expressed in macrophages and form a heteromultimeric channel. The hKv1.3-E314 antibody that we had generated as a specific hKv1.3 blocker inhibited outward delayed rectifier potassium currents, whereas the hKv1.5-E313 antibody that we had generated as a specific hKv1.5 blocker failed. Accordingly, the hKv1.3-E314 antibody reduced percentage of cholesterol ester and enhanced apoA-I-mediated cholesterol efflux in THP-1 macrophages and human monocyte-derived macrophages exposed to ox-LDL. The hKv1.3-E314 antibody downregulated SR-A, LOX-1, and ACAT1 expression and upregulated ABCA1 expression in THP-1 macrophages and human monocyte-derived macrophages. Our results reveal that specific Kv1.3 blockade represents a novel strategy modulating cholesterol metabolism in macrophages, which benefits the treatment of atherosclerotic lesions.

摘要

胆固醇代谢相关分子,包括清道夫受体 A 类(SR-A)、凝集素样氧化型低密度脂蛋白受体-1(LOX-1)、CD36、ACAT1、ABCA1、ABCG1 和清道夫受体 B 类 I 型,可调节巨噬细胞向泡沫细胞转化过程中的胆固醇代谢。电压门控钾通道 Kv1.3 越来越多地被证明在调节巨噬细胞功能方面发挥着重要作用。在这里,我们研究了 Kv1.3 在调节人急性单核细胞白血病细胞衍生的巨噬细胞(THP-1 巨噬细胞)和人单核细胞衍生的巨噬细胞中胆固醇代谢相关分子方面的作用,这些巨噬细胞暴露于氧化型低密度脂蛋白(ox-LDL)中。人 Kv1.3 和 Kv1.5 通道(hKv1.3 和 hKv1.5)在巨噬细胞中表达并形成异源多聚体通道。我们生成的特异性 hKv1.3 阻断剂 hKv1.3-E314 抗体抑制外向延迟整流钾电流,而我们生成的特异性 hKv1.5 阻断剂 hKv1.5-E313 抗体则不能。因此,hKv1.3-E314 抗体降低了胆固醇酯的百分比,并增强了 THP-1 巨噬细胞和暴露于 ox-LDL 的人单核细胞衍生巨噬细胞中载脂蛋白 A-I 介导的胆固醇流出。hKv1.3-E314 抗体下调了 THP-1 巨噬细胞和人单核细胞衍生巨噬细胞中 SR-A、LOX-1 和 ACAT1 的表达,上调了 ABCA1 的表达。我们的结果表明,特异性 Kv1.3 阻断代表了一种调节巨噬细胞中胆固醇代谢的新策略,有利于治疗动脉粥样硬化病变。

相似文献

1
Specific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL.特异性 Kv1.3 阻断剂可调节 ox-LDL 作用下人巨噬细胞中关键的胆固醇代谢相关分子。
J Lipid Res. 2013 Jan;54(1):34-43. doi: 10.1194/jlr.M023846. Epub 2012 Oct 24.
2
Foam cells in atherosclerosis.动脉粥样硬化中的泡沫细胞。
Clin Chim Acta. 2013 Sep 23;424:245-52. doi: 10.1016/j.cca.2013.06.006. Epub 2013 Jun 16.
3
Alpinetin enhances cholesterol efflux and inhibits lipid accumulation in oxidized low-density lipoprotein-loaded human macrophages.山姜素增强胆固醇流出并抑制氧化型低密度脂蛋白负载的人巨噬细胞中的脂质积累。
Biotechnol Appl Biochem. 2015 Nov-Dec;62(6):840-7. doi: 10.1002/bab.1328. Epub 2015 May 17.
4
GABA and topiramate inhibit the formation of human macrophage-derived foam cells by modulating cholesterol-metabolism-associated molecules.γ-氨基丁酸(GABA)和托吡酯通过调节胆固醇代谢相关分子来抑制人巨噬细胞源性泡沫细胞的形成。
Cell Physiol Biochem. 2014;33(4):1117-29. doi: 10.1159/000358681. Epub 2014 Apr 9.
5
Kaempferol suppresses lipid accumulation in macrophages through the downregulation of cluster of differentiation 36 and the upregulation of scavenger receptor class B type I and ATP-binding cassette transporters A1 and G1.山奈酚通过下调分化群 36 和上调清道夫受体 B 类 I 型和 ATP 结合盒转运体 A1 和 G1 抑制巨噬细胞中的脂质积累。
Int J Mol Med. 2013 Feb;31(2):331-8. doi: 10.3892/ijmm.2012.1204. Epub 2012 Dec 5.
6
Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis.赫赛汀-β1对巨噬细胞泡沫细胞形成和动脉粥样硬化的预防作用。
Circ Res. 2009 Aug 28;105(5):500-10. doi: 10.1161/CIRCRESAHA.109.193870. Epub 2009 Jul 30.
7
The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker.针对人 Kv1.3 孔区 E314 肽的抗体是一种新型、强效和特异的通道阻断剂。
PLoS One. 2012;7(4):e36379. doi: 10.1371/journal.pone.0036379. Epub 2012 Apr 27.
8
Nucleolin protects macrophages from oxLDL-induced foam cell formation through up-regulating ABCA1 expression.核仁素通过上调ABCA1的表达保护巨噬细胞免受氧化型低密度脂蛋白诱导的泡沫细胞形成。
Biochem Biophys Res Commun. 2017 Apr 29;486(2):364-371. doi: 10.1016/j.bbrc.2017.03.047. Epub 2017 Mar 14.
9
Reduced beta2-glycoprotein I protects macrophages from ox-LDL-induced foam cell formation and cell apoptosis.β2-糖蛋白 I 减少可保护巨噬细胞免受 ox-LDL 诱导的泡沫细胞形成和细胞凋亡。
Lipids Health Dis. 2013 Nov 16;12:174. doi: 10.1186/1476-511X-12-174.
10
Porphyromonas gingivalis lipopolysaccharide increases lipid accumulation by affecting CD36 and ATP-binding cassette transporter A1 in macrophages.牙龈卟啉单胞菌脂多糖通过影响巨噬细胞中的 CD36 和三磷酸腺苷结合盒转运体 A1 增加脂质积累。
Oncol Rep. 2013 Sep;30(3):1329-36. doi: 10.3892/or.2013.2600. Epub 2013 Jul 8.

引用本文的文献

1
Functional Potassium Channels in Macrophages.巨噬细胞中的功能性钾通道
J Membr Biol. 2023 Apr;256(2):175-187. doi: 10.1007/s00232-022-00276-4. Epub 2023 Jan 9.
2
Discovery of K 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.K1.3 离子通道抑制剂的发现:药物化学方法与挑战。
Med Res Rev. 2021 Jul;41(4):2423-2473. doi: 10.1002/med.21800. Epub 2021 May 1.
3
Critical regulation of atherosclerosis by the KCa3.1 channel and the retargeting of this therapeutic target in in-stent neoatherosclerosis.KCa3.1 通道对动脉粥样硬化的关键调节作用及其在支架内新生动脉粥样硬化中的治疗靶点再定位。
J Mol Med (Berl). 2019 Sep;97(9):1219-1229. doi: 10.1007/s00109-019-01814-9. Epub 2019 Jun 28.
4
Voltage Gated Potassium Channel Kv1.3 Is Upregulated on Activated Astrocytes in Experimental Autoimmune Encephalomyelitis.电压门控钾通道 Kv1.3 在实验性自身免疫性脑脊髓炎激活的星形胶质细胞中上调。
Neurochem Res. 2018 May;43(5):1020-1034. doi: 10.1007/s11064-018-2509-8. Epub 2018 Mar 24.
5
Mechanisms of foam cell formation in atherosclerosis.动脉粥样硬化中泡沫细胞形成的机制。
J Mol Med (Berl). 2017 Nov;95(11):1153-1165. doi: 10.1007/s00109-017-1575-8. Epub 2017 Aug 7.
6
Macrophage-mediated cholesterol handling in atherosclerosis.巨噬细胞介导的动脉粥样硬化中的胆固醇处理
J Cell Mol Med. 2016 Jan;20(1):17-28. doi: 10.1111/jcmm.12689. Epub 2015 Oct 23.
7
Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance.选择性 Kv1.3 通道阻滞剂作为肥胖和胰岛素抵抗的治疗药物。
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):E2239-48. doi: 10.1073/pnas.1221206110. Epub 2013 May 31.

本文引用的文献

1
Quercetin protects macrophages from oxidized low-density lipoprotein-induced apoptosis by inhibiting the endoplasmic reticulum stress-C/EBP homologous protein pathway.槲皮素通过抑制内质网应激-C/EBP 同源蛋白通路保护巨噬细胞免受氧化型低密度脂蛋白诱导的细胞凋亡。
Exp Biol Med (Maywood). 2012 Jul;237(7):822-31. doi: 10.1258/ebm.2012.012027. Epub 2012 Jul 24.
2
The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker.针对人 Kv1.3 孔区 E314 肽的抗体是一种新型、强效和特异的通道阻断剂。
PLoS One. 2012;7(4):e36379. doi: 10.1371/journal.pone.0036379. Epub 2012 Apr 27.
3
Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses.脂联素-脂联素受体 1/2-衔接蛋白 1 信号轴抑制人泡沫细胞形成:脂联素受体 1 和脂联素受体 2 调节炎症细胞因子反应的不同能力。
Atherosclerosis. 2012 Mar;221(1):66-75. doi: 10.1016/j.atherosclerosis.2011.12.014. Epub 2011 Dec 22.
4
A selective ACAT-1 inhibitor, K-604, stimulates collagen production in cultured smooth muscle cells and alters plaque phenotype in apolipoprotein E-knockout mice.一种选择性 ACAT-1 抑制剂 K-604 可刺激培养的平滑肌细胞产生胶原,并改变载脂蛋白 E 敲除小鼠的斑块表型。
Atherosclerosis. 2010 Nov;213(1):85-91. doi: 10.1016/j.atherosclerosis.2010.08.048. Epub 2010 Aug 19.
5
Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.慢性输注 salusin-α 和 -β 对载脂蛋白 E 缺乏小鼠动脉粥样硬化病变的发展产生相反的影响。
Atherosclerosis. 2010 Sep;212(1):70-7. doi: 10.1016/j.atherosclerosis.2010.04.027. Epub 2010 May 4.
6
Clinical pharmacokinetics of therapeutic monoclonal antibodies.治疗性单克隆抗体的临床药代动力学。
Clin Pharmacokinet. 2010 Aug;49(8):493-507. doi: 10.2165/11531280-000000000-00000.
7
Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses.载脂蛋白、ABCA1 和 ABCG1 转运体在胆固醇外排和免疫反应中的作用。
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):139-43. doi: 10.1161/ATVBAHA.108.179283. Epub 2009 Oct 1.
8
Protective effect of Astragalus polysaccharides on ATP binding cassette transporter A1 in THP-1 derived foam cells exposed to tumor necrosis factor-alpha.黄芪多糖对肿瘤坏死因子-α作用下人 THP-1 源性泡沫细胞三磷酸腺苷结合盒转运体 A1 的保护作用。
Phytother Res. 2010 Mar;24(3):393-8. doi: 10.1002/ptr.2958.
9
Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis.赫赛汀-β1对巨噬细胞泡沫细胞形成和动脉粥样硬化的预防作用。
Circ Res. 2009 Aug 28;105(5):500-10. doi: 10.1161/CIRCRESAHA.109.193870. Epub 2009 Jul 30.
10
Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.凝集素样氧化型低密度脂蛋白受体1(LOX-1)在动脉粥样硬化发生中的作用:简要综述
Curr Med Chem. 2009;16(21):2641-52. doi: 10.2174/092986709788681994.